Tafasitamab (MINJUVI) – Uses, Dosage & Brands in UAE

About Tafasitamab

Class:|Monoclonal antibody. Use:|Treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), in combination with lenalidomide. Adult dose:|12 mg/kg administered as an intravenous infusion on Days 1, 8, 15, and 22 of each 28-day cycle for the first 3 cycles, then on Days 1 and 15 of each cycle thereafter. Pediatric dose:|Safety and efficacy not established in pediatric patients. Side effects:|Common side effects include neutropenia, thrombocytopenia, anemia, fat

Drug Class

|Monoclonal antibody.

Uses & Indications

|Treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), in combination with lenalidomide.

Storage Requirements

Not available

Manufacturer & Packaging

Manufacturer: Incyte Biosciences International Sàrl[1110 Morges;Switzerland], Switzerland

Package Size

1 Glass Vial

Price & Supplier

Price in UAE: AED 4122.00

Dosage Information

Adult Dose

|12 mg/kg administered as an intravenous infusion on Days 1, 8, 15, and 22 of each 28-day cycle for the first 3 cycles, then on Days 1 and 15 of each cycle thereafter.

Pediatric Dose

|Safety and efficacy not established in pediatric patients.

Side Effects

|Common side effects include neutropenia, thrombocytopenia, anemia, fatigue, diarrhea, cough, fever, and peripheral edema.

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

Tafasitamab – Uses, Dosage, and Brands in UAE